Single Agent Lenalidomide in Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia

NCT01401322 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

5

Enrollment

OTHER

Sponsor class

Stopped low accrual

Conditions

Leukemia
Relapsed Adult Acute Lymphocytic Leukemia

Interventions

DRUG: Lenalidomide

Sponsor

Stanford University

Collaborators

[object Object]